Chinese PE Multimodality Imaging Artificial Intelligence Study

Recruiting now

Conditions studied: Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Disease

In brief

The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.

Key facts

Study ID

NCT06526468

Run by

China-Japan Friendship Hospital

People needed

1500

Starts

2010-09-01

Expected to finish

2028-09-01

Last updated by the study team

2024-08-28

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 14 Years and older
• Patients suspected of PE

You may not qualify if…

• Pregnant women
• Refuse to follow up
• Incomplete or discontinued imaging scans
• Insufficient quality of image data to allow for analysis

Where it is running

• China-Japan Frendship hospital — Beijing, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.